Treatment of diabetic neuropathy using special therapeutic socks

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of semiconductor embedded therapeutic socks in treating distal symmetric polyneuropathy, commonly known as diabetic neuropathy. The socks are designed to enhance blood circulation through the release of mid and far infrared waves and negative ions, which may alleviate symptoms and improve quality of life for patients. Participants will be assessed based on their diabetic neuropathy symptoms and will either receive the therapeutic socks or a placebo. The study aims to provide a novel approach to managing this prevalent condition, which currently has limited treatment options.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with mild to moderate Diabetic Neuropathy with a score between 2 and 7 out of 10 on the MNSI upon clinical examination and assessment.
* Patients reporting symptoms of Diabetic Neuropathy
* Patients age 18-79
* Patients who are willing and able to adhere to follow-up schedule and protocol guidelines
* Patients who are willing and able to sign corresponding research subject consent form

Exclusion Criteria:

* Patient has a history of neurodegenerative conditions, including multiple sclerosis or Parkinson's disease
* Patient has chronic pain conditions unrelated to diabetic neuropathy, including spinal stenosis, low back pain, and sciatica
* Patient has auto-immune or auto-inflammatory diseases other than Diabetic Neuropathy, including Multiple Sclerosis or Lyme Disease
* Patient has experienced a stroke
* Patient has any type of paralysis
* Patients with a score less than 2 and greater than 7 out of 10 on the MNSI upon clinical examination and assessment
* Patient has severe peripheral artery disease (with an ankle brachial index of \<0.7)
* Patient has chronic venous insufficiency (greater than stage 4)
* Patient has used tobacco within the last 90 days
* Patient has an open wound at the area of application
* Patient has started a new medication for diabetic neuropathy symptoms within the past 90 days
* Patient is not within the ages of 18-79
* Patient is unwilling or unable to sign the corresponding research subject consent form
* Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results

Where it's running

• Endocrine Research Solutions, Inc.
  Roswell, Georgia, United States Recruiting

Study contacts

• Principal investigator: John Reed — Endocrine Research Solutions. Inc.
• Study coordinator: Jessica Tapia
• Email: Endoresearch@gmail.com
• Phone: 6788784750

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Extended-release Pregabalin for nerve pain from diabetes or shingles

  This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.

  Recruiting at 15 sites Phase 3 Brainfarma Industria Química e Farmacêutica S/A · Salvador, Estado de Bahia and 14 other locations · NCT07712913

• LEEF shoe for reducing plantar pressure and improving acceptance in people with diabetic neuropathy

  This trial tests whether the LEEF shoe reduces pressure on the soles and is easier to wear for adults with diabetes-related neuropathy than standard custom orthopaedic shoes.

  Recruiting University Medical Center Groningen · Groningen, Provincie Groningen · NCT07488104

• Neural mobilization to reduce pain, improve balance, and boost quality of life in diabetic neuropathy

  This trial will test whether adding neural mobilization to balance training helps people with type 2 diabetic peripheral neuropathy have less pain, better balance, and improved quality of life.

  Recruiting Foundation University Islamabad · Islamabad · NCT07210203

• Melatonin for people with diabetic peripheral neuropathy

  This trial will test whether adding melatonin to usual care helps adults with type 2 diabetes who have peripheral neuropathy by reducing oxidative stress, lowering inflammation, and improving symptoms.

  Recruiting Phase 2 Ain Shams University · Cairo · NCT07036796

• Examining the link between diabetic neuropathy and muscle mass in type 2 diabetes patients

  This study looks at how diabetic nerve damage affects muscle mass and strength in people over 45 with type 2 diabetes.

  Recruiting at 2 sites Ain Shams University · Cairo, Abbassia and 1 other locations · NCT06958302

• Reiki's effects on pain and sleep in diabetic neuropathy patients

  This study tests whether second-level Reiki can help reduce pain and improve sleep for people with diabetic neuropathy.

  Recruiting TC Erciyes University · Kayseri, Kocasinan · NCT06668623

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.